A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature Chemical Biology

• Publication date

  2008-06-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nchembio.96PMID 18587388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tautomeric modification of GlcNAc-thiazoline.

  2007cited by this paper
• A 1-acetamido derivative of 6-epi-valienamine: an inhibitor of a diverse group of beta-N-acetylglucosaminidases.

  2007cited by this paper
• THE PROTECTIVE EFFECTS OF PUGNAC ON CARDIAC FUNCTION AFTER TRAUMA-HEMORRHAGE ARE MEDIATED VIA INCREASED PROTEIN O-GlcNAc LEVELS

  2007cited by this paper
• Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

  2007cited by this paper
• Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.

  2007cited by this paper
• Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor.

  2006cited by this paper
• Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β

  2006cited by this paper
• A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase.

  2006cited by this paper
• Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revert

  2006cited by this paper
• Cell signaling, the essential role of O-GlcNAc!

  2006cited by this paper
• An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.

  2006cited by this paper
• Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.

  2006cited by this paper
• An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice.

  2006cited by this paper
• Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting

  2006cited by this paper
• Structure and mechanism of a bacterial β-glucosaminidase having O-GlcNAcase activity

  2006cited by this paper
• GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels.

  2006cited by this paper
• Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants.

  2006cited by this paper
• O -GlcNAcase USES SUBSTRATE-ASSISTED CATALYSIS: KINETIC ANALYSIS AND DEVELOPMENT OF HIGHLY SELECTIVE MECHANISM-INSPIRED INHIBITORS.

  2005cited by this paper
• O-GlcNAcase Uses Substrate-assisted Catalysis

  2005cited by this paper
• O-GlcNAcase catalyzes cleavage of thioglycosides without general acid catalysis.

  2005cited by this paper
• O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

  2004cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.

  2003cited by this paper
• Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3β (GSK3β) plays a critical role in regulating tau's ability to bind and stabilize microtubules

  2003cited by this paper
• Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians.

  2002cited by this paper
• Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins

  2002cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II.

  2001cited by this paper
• Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine.

  2001cited by this paper
• Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins

  2001cited by this paper
• Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta.

  2000cited by this paper
• Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.

  1999cited by this paper
• Modulation of O-LinkedN-Acetylglucosamine Levels on Nuclear and Cytoplasmic Proteins in Vivo Using the PeptideO-GlcNAc-β-N-acetylglucosaminidase InhibitorO-(2-Acetamido-2-deoxy-dglucopyranosylidene)amino-N-phenylcarbamate*

  1998cited by this paper
• Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.

  1998cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• Dynamic Glycosylation of Nuclear and Cytosolic Proteins

  1997cited by this paper
• O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats*

  1997cited by this paper
• An Allosamizoline/Glucosamine Hybrid NAGase Inhibitor.

  1997cited by this paper
• NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation

  1996cited by this paper
• The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine*

  1996cited by this paper
• c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*)

  1995cited by this paper
• Stereochemistry of chitin hydrolysis by a plant chitinase/lysozyme and X-ray structure of a complex with allosamidin: evidence for substrate assisted catalysis.

  1995cited by this paper
• Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.

  1992cited by this paper
• Novel Chromogenic Substrates for the Rate-Assay of N-Acetyl-β-D-glucosaminidase: Resorufinyl- and Resazurinyl-N-acetyl-β-D-glucosaminides

  1992cited by this paper
• N‐Acetylgucosaminono‐1,5‐lactone oxime and the corresponding (phenylcarbamoyl)oxime

  1991cited by this paper
• N-acetylglucosaminono-1,5-lactone oxime and the corresponding (phenylcarbamoyl)oxime. Novel and potent inhibitors of beta-N-acetylglucosaminidase.

  1991cited by this paper
• Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques.

  1986cited by this paper
• Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc.

  1984cited by this paper
• Phosphorylation affects the ability of tau protein to promote microtubule assembly.

  1984cited by this paper
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

  1976cited by this paper

• Small molecule splicing modulators that disrupt O-GlcNAc homeostasis

  2026cites this paper
• Protein-encapsulated fluorogenic probes for the selective detection of endogenous O-GlcNAcase (OGA).

  2026cites this paper
• Catalyzing Carbohydrate Cleavage: Glycosidases and Their Mechanisms.

  2026cites this paper
• O-GlcNAcylation expression predicts a favorable prognosis and mitigates malignant phenotypes via MYCN suppression in neuroblastoma

  2026cites this paper
• Pharmacological inhibition of O-GlcNAcase reduces pS129-α-synuclein positive aggregates in the substantia nigra of mThy1-hSNCA mice.

  2026cites this paper
• A Scalable Design for Proximity-Inducing Molecules

  2026cites this paper
• Transcript‐Level Modulation of O‐GlcNAc Transferase for Aging‐Related Neurodegenerative Diseases

  2026cites this paper
• Impact of O‐GlcNAcylation Elevation on Mitophagy and Glia in the Dentate Gyrus

  2025cites this paper
• Comprehensive Evaluation of Cleavable Bioorthogonal Probes for Site-Specific O-GlcNAc Proteomics

  2025cites this paper
• DNA probe pulldown screening uncovers O-GlcNAcylation modulation of transcription factor DNA interactions

  2025cites this paper
• Neocortical tau propagation is a mediator of clinical heterogeneity in Alzheimer’s disease

  2025cites this paper
• Updates on tau-related drug targets and potential disease-modifying therapies for Alzheimer's disease.

  2025cites this paper
• Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications

  2025cites this paper
• FTO O-GlcNAcylation promotes TRIM21-mediated FTO ubiquitination degradation to sustain the negative feedback control of macrophage inflammation

  2025cites this paper
• Renal tubular GSDME protects cisplatin nephrotoxicity by impeding OGT-STAT3-S100A7A axis in male mice

  2025cites this paper
• Evidence for Functional Regulation of the KLHL3/WNK Pathway by O-GlcNAcylation.

  2025cites this paper
• In vivo quantification of [11C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcase

  2025cites this paper
• Targeted tau protein degradation: a promising therapeutic approach for tauopathies.

  2025cites this paper
• Hypoxia‐Induced circPRELID2 Promotes Gastric Cancer Metastasis by Facilitating ZEB2 Translation via PCBP1 O‐GlcNAcylation

  2025cites this paper
• Hydrolases & Lipases in GtoPdb v.2025.3

  2025cites this paper
• Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1

  2025cites this paper
• O-GlcNAcylation promotes angiogenic transdifferentiation to reverse vascular ischemia

  2025cites this paper
• Evidence for Functional Regulation of the KLHL3/WNK Pathway by O-GlcNAcylation

  2025cites this paper
• Dynamic O-GlcNAcylation and phosphorylation attract and expel proteins from RNA polymerase II to regulate mRNA maturation

  2025cites this paper
• O‐GlcNAcase Inhibitor Improves Denervation‐Induced Muscle Atrophy in Mice

  2025cites this paper
• Recent Progress of Small-molecule Inhibitors of O-GlcNAcase for Alzheimer's Disease.

  2025cites this paper
• Dynamic O-GlcNAcylation of Sec23-interacting protein regulates COPII function

  2025cites this paper
• Targeted protein O-GlcNAc reveals transcriptional functions for O-GlcNAc.

  2025cites this paper
• Glucose enrichment reduces lifespan and promotes tau phosphorylation in human tau-expressing C. elegans, unaffected by O-β-GlcNAcylation induction

  2025cites this paper
• A Genetically Encoded Assay System to Quantify O‐GlcNAc Transferase (OGT) Activity in Live Cells

  2025cites this paper
• Targeting O-GlcNAcylation: Novel Therapeutic Strategies for Neurological Disease

  2025cites this paper
• O‐GlcNAcylation Mediated by OGA Activates NEK7/NLRP3 Pathway to Promote Pyroptosis in Parkinson's Disease

  2025cites this paper
• Cross-Talk Between Tau O-GlcNAcylation and the Formation of the Early Driver of Neurodegeneration (Cis P-Thr231-Pro Tau) in Primary Cortical Neurons

  2025influential citation
• Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants

  2025cites this paper
• Brain Transcriptome Changes Associated With an Acute Increase of Protein O‐GlcNAcylation and Implications for Neurodegenerative Disease

  2025cites this paper
• O-GlcNAc modulation of nuclear pore complexes orchestrates mRNA export efficiency

  2025cites this paper
• Protein O‐GlcNAcylation in Health and Diseases

  2025cites this paper
• O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro

  2025influential citation
• A reference dataset of O-GlcNAc proteins in quadriceps skeletal muscle from mice.

  2025cites this paper
• Differences in intrinsic cellular O-GlcNAcylation impact response to metabolic stress

  2025cites this paper
• Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism

  2025cites this paper
• OGT's inner circle: Protein interactions and functional impact.

  2025cites this paper
• A tale of two sugars: O-GlcNAc and O-fucose orchestrate growth, development, and acclimation in plants.

  2025cites this paper
• Protein O-GlcNAcylation reprograms macrophage-mediated bone remodeling in medication-related osteonecrosis of the jaw.

  2025cites this paper
• Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration

  2025cites this paper
• O-GlcNAcylation regulates tyrosine hydroxylase serine 40 phosphorylation and L-DOPA levels.

  2025cites this paper
• Enzyme-Activated Sugar-Coated Bifunctional Degraders.

  2025cites this paper
• hnRNP R promotes O-GlcNAcylation of eIF4G and facilitates axonal protein synthesis

  2024cites this paper
• Acute increase of protein O-GlcNAcylation in mice leads to transcriptome changes in the brain opposite to what is observed in Alzheimer’s Disease

  2024cites this paper
• Influence of O-GlcNAcylation on KGN cell function

  2024cites this paper
• Insights into the role of glycosyltransferase in the targeted treatment of gastric cancer.

  2024cites this paper
• Optimization of bioactivities of solvent extracts of bark and heartwood of Pterocarpus marsupium and exploration of neuroprotective effect linking to the major Phytoconstituents

  2024cites this paper
• Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity

  2024cites this paper
• Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of Alzheimer’s disease by decreasing brain O-GlcNAc cycling in mice

  2024cites this paper
• Glycosylation: mechanisms, biological functions and clinical implications

  2024cites this paper
• Isoindoline-based fluorogenic probes bearing a self-immolative linker for the sensitive and selective detection of O-GlcNAcase activity.

  2024cites this paper
• Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy

  2024cites this paper
• Exploring the Role of Unconventional Post-Translational Modifications in Cancer Diagnostics and Therapy.

  2024cites this paper
• The post-translational modification O-GlcNAc is a sensor and regulator of metabolism

  2024cites this paper
• Discovery of 4-(Arylethynyl)piperidine Derivatives as Potent Nonsaccharide O-GlcNAcase Inhibitors for the Treatment of Alzheimer's Disease.

  2024cites this paper
• The importance of muscle glycogen phosphorylase in glial cells function.

  2024cites this paper
• O-GlcNAcylation in ischemic diseases

  2024cites this paper
• Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase.

  2024cites this paper
• Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.

  2024cites this paper
• Multi-Omics after O-GlcNAc Alteration Identifies Cellular Processes Working Synergistically to Promote Aneuploidy

  2024cites this paper
• The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.

  2024cites this paper
• O-GlcNAcylation Facilitates the Interaction between Keratin 18 and Isocitrate Dehydrogenases and Potentially Influencing Cholangiocarcinoma Progression

  2024cites this paper
• TFE3–SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells

  2024cites this paper
• O-GlcNAcylation: roles and potential therapeutic target for bone pathophysiology

  2024cites this paper
• Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants

  2024cites this paper
• O‐GlcNAc transferase promotes vascular smooth muscle calcification through modulating Wnt/β‐catenin signaling

  2024cites this paper
• Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease

  2024cites this paper
• Rescuable sleep and synaptogenesis phenotypes in a Drosophila model of O-GlcNAc transferase intellectual disability

  2024cites this paper
• Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting.

  2024cites this paper
• An Efficient and Accessible Hectogram-Scale Synthesis for the Selective O-GlcNAcase Inhibitor Thiamet-G

  2024cites this paper
• Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments

  2024cites this paper
• Proteasome activation: A novel strategy for targeting undruggable intrinsically disordered proteins.

  2024cites this paper
• O-GlcNAcylation and Its Roles in Neurodegenerative Diseases

  2024cites this paper
• Local thiamet-G delivery by a thermosensitive hydrogel confers ischemic cardiac repair via myeloid M2-like activation in a STAT6 O-GlcNAcylation-dependent manner.

  2024cites this paper
• Multi-omics after O-GlcNAc alteration identified cellular processes promoting aneuploidy after loss of O-GlcNAc transferase

  2024cites this paper
• Regulation of Glycogen Synthase Kinase-3β by Phosphorylation and O-β-Linked N-Acetylglucosaminylation: Implications on Tau Protein Phosphorylation.

  2024cites this paper
• Hydrolases & Lipases in GtoPdb v.2024.4

  2024cites this paper
• Phosphorylation of Tau Protein by CDK2/cyclin A and GSK3β Recombinant Kinases: Analysis of Phosphorylation Patterns by Nuclear Magnetic Resonance Spectroscopy.

  2024cites this paper
• Opportunities for Therapeutic Modulation of O-GlcNAc

  2024cites this paper
• Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?

  2023cites this paper
• Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer

  2023cites this paper
• Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263

  2023cites this paper
• Hydrolases in GtoPdb v.2023.1

  2023cites this paper
• Rescuable sleep and synaptogenesis phenotypes in a Drosophila model of O-GlcNAc transferase intellectual disability

  2023cites this paper
• Cognitive dysfunction and increased phosphorylated tau are associated with reduced O‐GlcNAc signaling in an aging mouse model of metabolic syndrome

  2023cites this paper
• Relationships between gene expression and behavior in mice in response to systemic modulation of the O‐GlcNAcylation pathway

  2023cites this paper
• IP-LC-MSMS Enables Identification of Three Tau O-GlcNAcylation Sites as O-GlcNAcase Inhibition Pharmacodynamic Readout in Transgenic Mice Overexpressing Human Tau.

  2023cites this paper
• The role of protein glycosylation in the occurrence and outcome of acute ischemic stroke.

  2023cites this paper
• Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53

  2023cites this paper
• Chemoproteomic and Transcriptomic Analysis Reveals that O-GlcNAc Regulates Mouse Embryonic Stem Cell Fate through the Pluripotency Network.

  2023cites this paper
• Evidence that only EWS among the FET proteins acquires a low partitioning property for the hyperosmotic stress response by O-GlcNAc glycosylation on its low-complexity domain.

  2023cites this paper
• Evaluating the impact of the hexosamine biosynthesis pathway and O-GlcNAcylation on glucose metabolism in bovine granulosa cells.

  2023cites this paper
• The effect of a methyl group on structure and function: Serine vs. threonine glycosylation and phosphorylation

  2023cites this paper
• Small Molecule-Activated O-GlcNAcase for Spatiotemporal Removal of O-GlcNAc in Live Cells.

  2023cites this paper
• Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain

  2023cites this paper